TMCnet News
Novavax to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceGAITHERSBURG, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference. Presentation details are as follows: Date: Tuesday, September 26, 2017 A replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com. About Novavax Novavax, Inc. (Nasda:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com. Contact: Investor Relations Media |